These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 31765283)

  • 1. Probiotics of Diverse Origin and Their Therapeutic Applications: A Review.
    Yadav M; Mandeep ; Shukla P
    J Am Coll Nutr; 2020 Jul; 39(5):469-479. PubMed ID: 31765283
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting gut flora to treat and prevent disease.
    Schneiderhan J; Master-Hunter T; Locke A
    J Fam Pract; 2016 Jan; 65(1):34-8. PubMed ID: 26845162
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Designer probiotics for the prevention and treatment of human diseases.
    Chua KJ; Kwok WC; Aggarwal N; Sun T; Chang MW
    Curr Opin Chem Biol; 2017 Oct; 40():8-16. PubMed ID: 28478369
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Probiotics and the prevention of necrotizing enterocolitis.
    Underwood MA
    J Pediatr Surg; 2019 Mar; 54(3):405-412. PubMed ID: 30241961
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Probiotics for prevention of necrotizing enterocolitis in preterm infants.
    AlFaleh K; Anabrees J
    Evid Based Child Health; 2014 Sep; 9(3):584-671. PubMed ID: 25236307
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gut microbiota and probiotics: Focus on diabetes mellitus.
    Bordalo Tonucci L; Dos Santos KM; De Luces Fortes Ferreira CL; Ribeiro SM; De Oliveira LL; Martino HS
    Crit Rev Food Sci Nutr; 2017 Jul; 57(11):2296-2309. PubMed ID: 26499995
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Unravelling the involvement of gut microbiota in type 2 diabetes mellitus.
    Arora A; Behl T; Sehgal A; Singh S; Sharma N; Bhatia S; Sobarzo-Sanchez E; Bungau S
    Life Sci; 2021 May; 273():119311. PubMed ID: 33662428
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Probiotics and necrotizing enterocolitis.
    Patel RM; Underwood MA
    Semin Pediatr Surg; 2018 Feb; 27(1):39-46. PubMed ID: 29275816
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of probiotics and gut microbiota on anti-cancer drugs: Mechanistic perspectives.
    Badgeley A; Anwar H; Modi K; Murphy P; Lakshmikuttyamma A
    Biochim Biophys Acta Rev Cancer; 2021 Jan; 1875(1):188494. PubMed ID: 33346129
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bifidobacterium and Lactobacillus for preventing necrotizing enterocolitis in very-low-birth-weight preterm infants: a systematic review and meta-analysis.
    Jiao X; Fu MD; Wang YY; Xue J; Zhang Y
    World J Pediatr; 2020 Apr; 16(2):135-142. PubMed ID: 31482480
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gut Microbiota as a Therapeutic Target for Metabolic Disorders.
    Okubo H; Nakatsu Y; Kushiyama A; Yamamotoya T; Matsunaga Y; Inoue MK; Fujishiro M; Sakoda H; Ohno H; Yoneda M; Ono H; Asano T
    Curr Med Chem; 2018; 25(9):984-1001. PubMed ID: 28990516
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Holobionts: emerging strategy for interventions against infectious diseases, metabolic disorders & cancer.
    Singh Y; Hasnain SE
    Indian J Med Res; 2014 Jul; 140(1):11-4. PubMed ID: 25222772
    [No Abstract]   [Full Text] [Related]  

  • 13. Gut microbiota and probiotics intervention: A potential therapeutic target for management of cardiometabolic disorders and chronic kidney disease?
    Cavalcanti Neto MP; Aquino JS; Romão da Silva LF; de Oliveira Silva R; Guimarães KSL; de Oliveira Y; de Souza EL; Magnani M; Vidal H; de Brito Alves JL
    Pharmacol Res; 2018 Apr; 130():152-163. PubMed ID: 29410236
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gut microbiota and probiotic intervention as a promising therapeutic for pregnant women with cardiometabolic disorders: Present and future directions.
    de Brito Alves JL; de Oliveira Y; Carvalho NNC; Cavalcante RGS; Pereira Lira MM; Nascimento LCPD; Magnani M; Vidal H; Braga VA; de Souza EL
    Pharmacol Res; 2019 Jul; 145():104252. PubMed ID: 31054952
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Engineering probiotics as living diagnostics and therapeutics for improving human health.
    Zhou Z; Chen X; Sheng H; Shen X; Sun X; Yan Y; Wang J; Yuan Q
    Microb Cell Fact; 2020 Mar; 19(1):56. PubMed ID: 32131831
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Guidance for substantiating the evidence for beneficial effects of probiotics: prevention and management of infections by probiotics.
    Wolvers D; Antoine JM; Myllyluoma E; Schrezenmeir J; Szajewska H; Rijkers GT
    J Nutr; 2010 Mar; 140(3):698S-712S. PubMed ID: 20107143
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of oral probiotics supplementation in the prevention of necrotizing enterocolitis among very low birth weight preterm infants.
    Saengtawesin V; Tangpolkaiwalsak R; Kanjanapattankul W
    J Med Assoc Thai; 2014 Jun; 97 Suppl 6():S20-5. PubMed ID: 25391168
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Probiotic Supplementation During the Perinatal and Infant Period: Effects on Gut Dysbiosis and Disease.
    Navarro-Tapia E; Sebastiani G; Sailer S; Toledano LA; Serra-Delgado M; García-Algar Ó; Andreu-Fernández V
    Nutrients; 2020 Jul; 12(8):. PubMed ID: 32727119
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral probiotics reduce the incidence and severity of necrotizing enterocolitis in very low birth weight infants.
    Lin HC; Su BH; Chen AC; Lin TW; Tsai CH; Yeh TF; Oh W
    Pediatrics; 2005 Jan; 115(1):1-4. PubMed ID: 15629973
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Necrotizing Enterocolitis and the Preterm Infant Microbiome.
    Baranowski JR; Claud EC
    Adv Exp Med Biol; 2019; 1125():25-36. PubMed ID: 30680646
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.